Effects of neuropathic pain on intestinal barrier function based on the "brain-gut axis" and logistic regression model

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400085092

Enrollment

Unknown

Registered

2024-05-30

Start date

2024-06-01

Completion date

Unknown

Last updated

2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic pain

Interventions

Observation group:None

Eligibility

Sex/Gender

All

Age

50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. patients with neuropathic pain attending our pain department from June 2024 to December 2024 2. Good cardiopulmonary function 3. Normal liver and kidney function 4. No gastrointestinal diseases 5. The patient is compliant, cooperative, and able to complete the required tests. 6. The patient and his/her family sign an informed consent form. 7. The patient has not participated in other clinical trials

Exclusion criteria

Exclusion criteria: 1. History of surgery of gastrointestinal system 2. History of gastrointestinal system diseases 3. Previous radiotherapy treatment 4. Combined hematologic diseases 5. Combined autoimmune system disease

Design outcomes

Primary

Measure	Time frame
D-lactic acid;Intestinal fatty acid binding protein;Diamine oxidase;visual analogue scale, VAS;	—

Secondary

Measure	Time frame
Operative time;Operation types ;	—

Countries

China

Contacts

Public ContactWu Jie; Zhang Jialei

Changzhi People's Hospital affiliated with Changzhi Medical College

zjlbigeye@163.com+86 155 2517 6091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026